Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov 1;33(31):3541-3.
doi: 10.1200/JCO.2015.61.6870. Epub 2015 Aug 10.

Pseudoprogression and Immune-Related Response in Solid Tumors

Victoria L Chiou  1 , Mauricio Burotto  2
Affiliations

Pseudoprogression and Immune-Related Response in Solid Tumors

Victoria L Chiou et al. J Clin Oncol. .
No abstract available

PubMed Disclaimer

Comment in

  • Integration of Immuno-Oncology and Palliative Care.
    Wong A, Fullerton S, Spruyt O, Brady B, McArthur G, Sandhu S. Wong A, et al. J Clin Oncol. 2016 May 1;34(13):1561-2. doi: 10.1200/JCO.2015.64.4146. Epub 2016 Feb 29. J Clin Oncol. 2016. PMID: 26926686 No abstract available.
  • Reply to A. Wong et al.
    Chiou VL, Burotto M. Chiou VL, et al. J Clin Oncol. 2016 May 1;34(13):1562-3. doi: 10.1200/JCO.2015.66.2031. Epub 2016 Feb 29. J Clin Oncol. 2016. PMID: 26926687 Free PMC article. No abstract available.

References

    1. Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: Integrating immunity's roles in cancer suppression and promotion. Science. 2011;331:1565–1570. - PubMed
    1. Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12:252–264. - PMC - PubMed
    1. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205–216. - PubMed
    1. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) Eur J Cancer. 2009;45:228–247. - PubMed
    1. Fojo AT, Noonan A. Why RECIST works and why it should stay: Counterpoint. Cancer Res. 2012;72:5151–5157. - PubMed

MeSH terms